China Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

China’s infection control market is evaluated at US$ 1,919.47 million for the year 2020 and is projected to grow at a CAGR of 19.03% to reach a market size of US$ 6,496.62 million by the year 2027.    

In the People's Republic of China, the premium of primary insurance received by the insurance companies was to the tune of 4,264.5 billion yuan in 2019, which was an increase of 12.2 % over that of the previous year. Out of this entire sum of life insurance, primary insurance amounted to 2,275.4 billion yuan, health and casualty insurance premium for primary insurance was 824.1 billion yuan, and property insurance premium of primary insurance was 1,164.9 billion yuan. Contrarily the Insurance companies paid an indemnity worth 1,289.4 billion yuan, of which life insurance indemnity was 374.3 billion yuan, health and casualty insurance indemnity 264.9 billion yuan, among others. Thereby it delineates the fact that there has been room for expenditure pertaining to healthcare.

Further, the per capita disposable income nationwide was 30,733 yuan, an increase of 8.9 % compared to the preceding year. Further, by the end of 2019, there were around 1,014,000 medical and health institutions in China, including 34,000 hospitals. Of the 17,000 professional public health institutions, 3,456 were disease control and prevention centres, and 3,106 were health monitoring institutions. Further, the total number of medical visits and hospital discharges in 2019 reached 8.52 billion and 270 million, respectively [Source: National Bureau of Statistics of China]. Therefore, the aforesaid facts and figures, along with burgeoning expenses that are borne by the government to extend various healthcare offerings, will require further investments in infection control products to prevent any healthcare-associated infection (HCAI). Thereafter providing the thrust to the clinical infection control market of China during the forecast period.

Another segment that is poised to push infection control market growth in China to new horizons during the forecast is the food and beverage sector. To this end, it should be noted that during 2019 6.01 billion domestic tourists were registered, an increase of 8.4% over that of the previous year. The revenue generated by domestic tourism alone totalled 5,725.1 billion yuan, which is an increase of 11.7% from the preceding year.  Further, the number of inbound visitors to China was to the tune of 145.31 million, which is an increase of 2.9 %. The receipts from tourism were to the tune of 131.3 billion US dollars, an increment of 3.3 percent compared to the previous year. Therefore, by the aforementioned increments, it is discerned with certitude that there is a growing number of visits to the country. Besides, the per capita disposable income of urban households was 42,359 yuan, an increase of 7.9% from the previous year [Source: National Bureau of Statistics of China]. This is also enabling the population in China to be inclined towards spending on food and beverage establishments and availing the same in more quantities and frequency. Therefore, to provide a smooth and memorable experience, all the stakeholders involved in the food and beverage segment need to adhere to the strictest standards of hygiene to prevent any discomfort to their consumers, simultaneously upholding their brand image and preventing any possible loss in revenue. Therefore, increased investment in infection prevention products and solutions is expected, which in turn is projected to fuel the infection control market growth.

COVID-19 SCENARIO

With the government closely monitoring population growth and newly diagnosed cases, COVID-19 had a beneficial impact on the Chinese infection control market. As a result, demand for infection prevention goods is anticipated to soar. Additionally, expanding the use of these medicines to fend off possible virus attacks would accelerate the growth of the infection prevention market. Additionally, major companies in this area are concentrating on new product launches and utilising inorganic growth techniques, such as partnerships with regional companies to broaden their service offerings, which is predicted to accelerate the growth of the infection control market in China.

China Infection Control Market Scope:

Market Segmentation

• By Product
  • Disinfectants
  • Sterilization
    • Low-Temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End-User Industry
  • Healthcare
  • Food and Beverage
  • Chemical